Clinical Trials

87 enrolled

Other solid neoplasm

Solid Tumour Refractory to Conventional Treatment

NCT01818323 2024-10-09

Phase I Trial: T4 Immunotherapy of Head and Neck Cancer

Head & Neck

Head and Neck Neoplasms

NCT06556004 2024-08-15

Trimelvax001

Dermatologic

Melanoma

NCT05183243 2024-07-16

GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results

GastrointestinalHead & NeckThoracic

68 enrolled

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT05735028 2024-04-17

The Efficacy and Safety of PD-1/PD-L1 Inhibitors Combined With Centipeda Minima (CM) in Lung Cancer

8 enrolled

Lung Neoplasms

NCT06356701 2024-04-10

Tumor Nutritional Therapy in the First-line Treatment of Stage IV NSCLC

120 enrolled

Lung Neoplasms

NCT06225622 2024-03-19

Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer

78 enrolled

Colorectal Neoplasms

NCT03291444 2024-03-15

CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06304597 2024-03-12

PREDICT

18 enrolled

Locally Advanced Rectal Carcinoma

NCT06300489 2024-03-08

Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

Rectal Neoplasms

NCT04766320 2024-03-06

Study on TIL for the Treatment of r/r Gynecologic Tumors

15 enrolled

Gynecologic

Gynecologic Cancer

NCT06225921 2024-03-06

Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas

6 enrolled

Esophageal Squamous Cell Carcinoma

NCT06283303 2024-02-29

A Clinical Study of T3011 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer

8 enrolled

Colorectal Neoplasms

NCT06281860 2024-02-28

PITHAC

BreastGastrointestinalGynecologicOther solid neoplasmThoracic

39 enrolled

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT05829057 2024-02-13

The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1

GastrointestinalGenitourinaryGynecologicThoracic

10 enrolled

Urinary Bladder Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Neoplasms, Ovarian Neoplasms, Small Cell Lung Carcinoma

NCT05028933 2024-02-12

IMC001 for Clinical Research on Advanced Digestive System Malignancies

48 enrolled

Advanced Hepatocellular Carcinoma

NCT05213195 2024-02-12

NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer

38 enrolled

Colorectal Neoplasms

NCT06240767 2024-02-05

Clinical Study on the Treatment of Advanced Recurrent Tumors With Anticancer Mouse Characteristic Human Neutrophils

18 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT05291182 2024-02-02

A Phase I Study of SY-4835 in Patients With Advanced Solid Tumors

40 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT04961632 2024-02-01

Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376

75 enrolled

Breast

Breast Neoplasms

NCT05573373 2024-01-31

Pamiparib (BGB-290) Was Used in EGFR-TkIs Resistant Non-small Cell Lung Cancer

40 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03068624 2024-01-25

Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma

34 enrolled

Dermatologic

Uveal Melanoma

NCT04224480 2024-01-19

Longitudinal Immune-phenotyping of HCC Following MK-3475

8 enrolled

Carcinoma, Hepatocellular

NCT06200363 2024-01-11

A Clinical Study of T3011 in Combination With Regorafenib in Patients With Advanced Colorectal Cancer

15 enrolled

Advanced Colorectal Cancer

NCT06200376 2024-01-11

A Clinical Study of Intraperitoneal T3011 Given as a Single Agent in Patients With Malignant Ascites Induced by Advanced Colorectal Cancer

10 enrolled

Malignant Ascites

NCT06187740 2024-01-09

Thoracic Consolidation Radiotherapy for ES-SCLC Treated With Chemo-immunotherapy

28 enrolled

Small Cell Lung Carcinoma

NCT05185531 2024-01-05

Notable-HCC

Carcinoma, Hepatocellular

NCT06182735 2023-12-27

CD70-targeted CAR-NKT Cells(CGC729) Therapy in the Renal Cell Carcinoma

9 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT04324294 2023-12-20

Contrast Enhanced Endoscopic Ultrasound in Pancreas Lesions

200 enrolled

Pancreatic Cyst, Pancreatic Neoplasms, Pancreatitis

NCT05031949 2023-12-19

CCGLC-003

Carcinoma, Hepatocellular

NCT05533892 2023-12-19

CCGLC-007

Carcinoma, Hepatocellular

NCT04431648 2023-12-13

USmBRT-H

Head & Neck

Head and Neck Neoplasms

NCT04727008 2023-12-12

CXCR4 Modified Anti-BCMA CAR T Cells for Multiple Myeloma

12 enrolled

Plasma cell

Multiple Myeloma

NCT04599556 2023-12-06

Clinical Trial for the Safety and Efficacy of Anti-CD7 CAR-T Cell Therapy for Patients With Relapsed or Refractory CD7 Positive Hematological Malignancy

LymphoidOther hematologic neoplasm

81 enrolled

CD7+ Acute Leukemia

NCT05477927 2023-11-29

Dual-targeting VEGFR1 and PD-L1 CAR-T for Cancers Patients With Pleural or Peritoneal Metastases

58 enrolled

Malignant Peritoneal Effusion

NCT06147362 2023-11-27

68Ga-NOTA-PEG2-RM26 PET/CT, First in Man Study

50 enrolled

Tumor-Agnostic

Neoplasms

NCT02915445 2023-11-22

EpCAM CAR-T for Treatment of Advanced Solid Tumors

BreastGastrointestinalHead & NeckOther neoplasm

Malignant Neoplasm of Nasopharynx TNM Staging Distant Metastasis (M)

NCT03582514 2023-11-18

POBIG

18 enrolled

CNS

Glioblastoma

NCT06127940 2023-11-13

K-SAB

Non-small Cell Lung Cancer Metastatic

NCT06125106 2023-11-09

Prospective, Single-arm, Multicenter Clinical Study on Haploidentical Hematopoietic Stem Cell Transplantation in Patients With MRD Positive CD19+ALL Treated With Conditioning Regimens Containing Blinatumomab

LymphoidOther hematologic neoplasm

31 enrolled

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02229656 2023-11-07

Olaparib and Radiotherapy in Head and Neck Cancer

12 enrolled

Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms

NCT00930228 2023-11-02

CRM004

72 enrolled

Polycystic Ovary Syndrome

NCT01428089 2023-11-02

Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone

40 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

NCT06095674 2023-10-23

ITHACA

Gynecologic

Uterine Cervical Neoplasms

NCT05259319 2023-10-17

IMMUNOs-SBRT

GenitourinaryHead & NeckThoracic

92 enrolled

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Neoplasms

NCT06081322 2023-10-13

CISPD-5

29 enrolled

Cholangiocarcinoma

NCT06078982 2023-10-12

Posterior-line Treatment With Disitamab Vedotin Plus PD-1 in Advanced HER2-low Expressing Gastric Cancer

39 enrolled

Stomach Neoplasms

NCT06080984 2023-10-12

The Application of Novel Oncolytic Virus in Late Stage Solid Tumors

24 enrolled

Tumor-Agnostic

Neoplasms

NCT04303403 2023-10-11

Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic Adenocarcinoma

48 enrolled